Methotrexate treatment of rheumatoid arthritis. 1985

R F Willkens

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

R F Willkens
January 1989, Cleveland Clinic journal of medicine,
R F Willkens
April 1996, Schweizerische medizinische Wochenschrift,
R F Willkens
February 2004, Postepy higieny i medycyny doswiadczalnej (Online),
R F Willkens
January 2009, Nederlands tijdschrift voor geneeskunde,
R F Willkens
September 2011, Ugeskrift for laeger,
R F Willkens
January 1996, Duodecim; laaketieteellinen aikakauskirja,
R F Willkens
January 1986, Terapevticheskii arkhiv,
R F Willkens
December 1988, Zhonghua nei ke za zhi,
R F Willkens
October 1989, American family physician,
Copied contents to your clipboard!